Moncada S., Vane JRUnstable metabolites of arachidonic acid and their role in haemostasis and thrombosis. Br Med Bull1978; 34: 129-35.
2.
Tulppala M., Viinikka L., Ylikorkala O.Thromboxane dominance and prostacyclin deficiency in habitual abortion . Lancet1991; 337: 879-81.
3.
Kaaja R., Julkunen H., Viinikka L., Ylikorkala O.Production of prostacyclin and thromboxane in lupus pregnancies: effect of small dose of aspirin. Obstet Gynecol1993 ; 81: 327-31.
4.
Carreras LO, Defreyn G., Machin SJ et al. Recurrent arterial thrombosis, repeated intrauterine death and 'lupus' anticoagulant. Detection of immunoglobulin interfering with prostacyclin formation. Lancet1981; 1: 244-6.
5.
Carreras LO, Vermylen J., Spitz B., van Assche A.'Lupus' anticoagulant and inhibition of prostacyclin formation in patients with repeated abortion, intrauterine growth retardation and intrauterine death . Br J Obstet Gynaecol1981; 88: 890-4.
6.
Carreras LO, 'Vermylen JG'Lupus' anticoagulant and thrombosis. Possible role of inhibition of prostacyclin formation. Thromb Haemos1982 ; 48: 38-40.
7.
De Wolf F., Carreras LO, Moerman P., Vermylen J., van Assche A., Renaer M.Decidual vasculopathy and extensive placental infarction in a patient with repeated thromboembolic accidents, recurrent fetal loss and a lupus anticoagulant . Am J Obstet Gynecol1982; 142: 829-34.
8.
De Castellarnau C., Vila L., Sancho MJ, Borrell M., Fontcuberta J., Rutllant MLLupus anticoagulant, recurrent abortion and prostacyclin production by cultured smooth muscle cells . Lancet1983; 2: 1137-8.
9.
Elias M., Eldor A.Thromboembolism in patients with the 'lupus' type circulating anticoagulant . Arch Intern Med1984; 144: 510-15.
10.
Schorer AE, Wickham Nwr, Watson KVLupus anticoagulant induces a selective defect in thrombin-mediated endothelial prostacyclin release and platelet aggregation. Br J Haematol1989; 71: 399-407..
11.
Watson KV, Schorer AELupus anticoagulant inhibition of in vitro prostacyclin release is associated with a thrombosis-prone subset of patients. Am J Med1991; 90: 47-53.
Rustin Mha, Bull HA, Machin SJ, Isenberg DA, Snaith ML, Dowd PMEffects of the lupus anticoagulant in patients with systemic lupus erythematosus on endothelial cell prostacyclin release and procoagulant activity. J Invest Dermatol1988; 90: 744-8.
14.
Coade SB, van Haaren E., Loizou S., Walport MJ, Denman AM, Pearson JDEndothelial prostacyclin release in systemic lupus erythematosus. Thromb Haemos1989; 61: 97-100.
15.
Dudley DJ, Mitchell MD, Branch DWPathophysiology of antiphospholipid antibodies: absence of prostaglandin-mediated effects on cultured endothelium. Am J Obset Gynecol1990; 162: 953-8.
16.
Cariou R., Tobelem G., Bellucci S. et al. Effect of lupus anticoagulant on antithrombogenic properties of endothelial cells. Inhibition of thrombomodulin-dependent protein C activation . Thromb Haemost1988; 60: 54-8.
17.
Petraiuolo W., Bovill E., Hoak J.The lupus anticoagulant stimulates the release of prostacyclin from human endothelial cells. Thromb Res1988; 50:847-55.
18.
Walker TS, Triplett DA, Javed N., Musgrave K.Evaluation of lupus anticoagulants: antiphospholipid antibodies, endothelium-associated immunoglobulin, endothelial prostacyclin secretion and antigenic protein S levels. Thromb Res1988; 51: 267-81.
19.
Hasselaar P, DerksenRHWM, Blokzijl L, de Groot PG. Thrombosis associated with antiphospholipid antibodies cannot be explained by effects on endothelial and platelet prostanoid synthesis. Thromb Haemost1988; 59: 80-5.
20.
Lindsey N., Henderson F., Malia R., Greaves M., Hughes P.Serum masks the inhibition of thrombin-induced prostacyclin release produced by anticardiolipin antibodies. Br J Rheumatol1992; 31: 179-83.
21.
Lellouche F. , Martinuzzo M., Said P., Maclouf J., Carreras LOImbalance of thromboxane/prostacyclin biosynthesis in patients with lupus anticoagulant . Blood1991; 78: 2894-9.
22.
Catella F., Healy D., Lawson JA, FitzGerald GA11-dehydrothromboxane B2: a quantitative index of thromboxane A2 formation in the human circulation. Proc Natl Acad Sci USA1986; 83: 5861-5.
Violi F., Davi G., Ferro D., Valesini G., Iuliano L., Leo R., Patrono C.Thromboxane biosynthesis in patients with systemic lupus erythematosus . Thromb Haemost1993; 69: 541 (abstract).
25.
Lellouche F. , Falcón C., Carreras L., Maclouf J.Selective inhibition of platelet-derived thromboxane A2 in patients with lupus anticoagulant using low doses aspirin as assessed by enzyme immunoassay. In: Advances in Prostaglandins, Thromboxane and Leukotrienes Research , vol. 21, pp. 611-14. Samuelsson B, Ramwell PW, Paoletti R, Folco G, Granstrom E (eds). New York, Raven Press, 1990.
Lin YL, Wang CTActivation of human platelets by the rabbit anticardiolipin antibodies. Blood1992; 80: 3135-43.
28.
Lockshin MD , Druzin ML, Qamar T.Prednisone does not prevent recurrent fetal death in women with antiphospholipid antibodies. Am J Obstet Gynecol1989; 160: 439-43.
29.
FitzGerald GA, Smith B., Pederson AK, Brash ARIncreased prostacyclin biosynthesis in patients with severe atherosclerosis and platelet activation . New Engl J Med1984; 310: 1065-8.
30.
Fitzgerald DJ, Roy L., Catella F., FitzGerald GAPlatelet activation in unstable coronary disease . New Engl J Med1986; 315: 983-9.
31.
Reilly Iag, Roy L., FitzGerald GABiosynthesis of thromboxane in patients with systemic sclerosis and Raynaud's phenomenon. Br Med J1986; 292: 1037-9.
32.
Carreras LO, Vermylen J.Antiphospholipid antibodies and impairment of prostacyclin synthesis by endothelium . In Phospholipid Binding Antibodies, pp. 231-245. Haris EN, Exner T, Hughes GRV, Asherson RA (eds). Boca Raton, Florida: CRC Press, 1991.
33.
Carreras LO , Maclouf J.The lupus anticoagulant and eicosanoids. ProstaglandinsLeukotrienes and Essential Fatty Acids1993 ; 49: 483-8.
